3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
8
Neoplasms
5
Adenocarcinoma
5
Solid Tumors
2
Pancreatic Neoplasms
1
Metastatic Pancreatic Adenocarcinoma
1
Gastric Cancer Adenocarcinoma Metastatic
1
Esophageal Neoplasms
1
CLDN18.2-positive Gastric Adenocarcinoma
1
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
1
Adenocarcinoma Of Esophagus
1
Interventions
zolbetuximab
1
trifluridine tipiracil drug combination
1
tipiracil
1
camrelizumab
1
Trifluridine
1
Taxes
1
Oxaliplatin
1
HMPL-013
1
Docetaxel
1
Cetuximab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Gastric Cancer Adenocarcinoma Metastatic
×
zolbetuximab
×
Clear all
NCT06962137
2025-12-22
RAINSPOT
Universitaire Ziekenhuizen KU Leuven
Phase 2
Recruiting
100 enrolled